Document is current
Any future updates will be listed below
-
Authors
Hochhaus, Andreas https://orcid.org/0000-0003-0626-0834
Réa, Delphine
Boquimpani, Carla
Minami, Yosuke https://orcid.org/0000-0003-0863-0739
Cortes, Jorge E. https://orcid.org/0000-0002-8636-1071
Hughes, Timothy P.
Apperley, Jane F. https://orcid.org/0000-0002-1710-1794
Lomaia, Elza
Voloshin, Sergey
Turkina, Anna https://orcid.org/0000-0001-9947-2371
Kim, Dong-Wook
Abdo, Andre
Fogliatto, Laura Maria
le Coutre, Philipp
Sasaki, Koji https://orcid.org/0000-0002-9140-0610
Kim, Dennis Dong Hwan
Saussele, Susanne https://orcid.org/0000-0003-0357-5785
Annunziata, Mario
Chaudhri, Naeem
Chee, Lynette https://orcid.org/0000-0002-4250-4448
García-Gutiérrez, Valentin https://orcid.org/0000-0003-4752-0815
Kapoor, Shruti
Allepuz, Alex
Quenet, Sara
Bédoucha, Véronique
Mauro, Michael J. https://orcid.org/0000-0002-2251-4032
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
- License Information
-
More Information
Article History
Received: 6 January 2023
Revised: 12 January 2023
Accepted: 18 January 2023
First Online: 30 January 2023
Competing interests
: The authors declare the following potential conflicts of interest: AH received institutional research support from Novartis, Bristol Myers Squibb, Incyte, and Pfizer and personal fees from Novartis and Incyte. DR received personal fees from Novartis, Pfizer, and Incyte. CB received grants from Novartis during the conduct of the study. YM received honoraria from Bristol Myers Squibb, Novartis, Pfizer, and Astellas. JEC received grants and consulting fees from Novartis, grants and consulting fees from Pfizer, and grants from Bristol Myers Squibb. TPH received grants and honoraria for advisory boards and symposia from Novartis and grants from Bristol Myers Squibb. JFA received honoraria, grants, and personal fees from Novartis and grants and personal fees from Pfizer. EL received grants from Novartis and personal fees and non-financial support from Novartis, Pfizer, and Bristol Myers Squibb. SV received personal fees and non-financial support from Novartis, AbbVie, Janssen, Sanofi, and BIOCAD; non-financial support from Pfizer; and personal fees from Takeda and AstraZeneca. AT declares no competing financial interests. D-WK received grants from Novartis, Bristol Myers Squibb, Pfizer, ILYANG, and Takeda. AAbdo received honoraria from Novartis and Takeda. LMF declares no competing financial interests. PlC received speaker’s honoraria from Novartis, Incyte, Pfizer, and Bristol Myers Squibb. KS received research funding and honoraria for advisory boards from Novartis. DDHK received grants, honoraria, and consulting fees from Novartis; grants from Bristol Myers Squibb; and honoraria from Pfizer and Paladin. SS received honoraria, grants, and personal fees from Novartis and grants and personal fees from Bristol Myers Squibb and Incyte, and honoraria from Roche and Pfizer. MA declares no competing financial interests. NC declares no competing financial interests. LC received honoraria and participated in advisory boards for Novartis and Otsuka. VG-G received grants, non-financial support, and honoraria from Novartis, Pfizer, Bristol Myers Squibb, and Incyte. SK is an employee of Novartis. AAllepuz is an employee of Novartis. SQ is an employee of Novartis. VB is an employee of Novartis. MJM received personal fees from Bristol Myers Squibb, Takeda, and Pfizer.
